← Browse by Condition
Medical Condition

mrd positive

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05940961 Phase 2
Recruiting

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Enrollment
42 pts
Location
China
Sponsor
Sheng-Li Xue, MD
View Trial →